-
1
Thrombopoietin receptor agonist antibody for treating chemotherapy-induced thrombocytopenia
Published 2023-05-01Subjects: Get full text
Article -
2
OX40‐targeted immune agonist antibodies induce potent antitumor immune responses without inducing liver damage in mice
Published 2021-10-01Subjects: Get full text
Article -
3
FGF21 mimetic antibody stimulates UCP1-independent brown fat thermogenesis via FGFR1/βKlotho complex in non-adipocytes
Published 2017-11-01Subjects: Get full text
Article -
4
Design of a humanized CD40 agonist antibody with specific properties using AlphaFold2 and development of an anti-PD-L1/CD40 bispecific antibody for cancer immunotherapy
Published 2025-02-01Subjects: “…Agonist antibody…”
Get full text
Article -
5
-
6
Adrenergic receptor signaling regulates the CD40-receptor mediated anti-tumor immunity
Published 2023-03-01Subjects: Get full text
Article -
7
Preserving neuromuscular synapses in ALS by stimulating MuSK with a therapeutic agonist antibody
Published 2018-02-01Subjects: Get full text
Article -
8
An Autocrine TNFα–Tumor Necrosis Factor Receptor 2 Loop Promotes Epigenetic Effects Inducing Human Treg Stability In Vitro
Published 2018-03-01Subjects: “…tumor necrosis factor receptor 2 agonist antibody…”
Get full text
Article -
9
-
10
VISTA: A Target to Manage the Innate Cytokine Storm
Published 2021-02-01Subjects: Get full text
Article -
11
Targeting fibroblast growth factor (FGF)-inducible 14 (Fn14) for tumor therapy
Published 2022-10-01Subjects: “…agonistic antibodies…”
Get full text
Article -
12
FcγR requirements and costimulatory capacity of Urelumab, Utomilumab, and Varlilumab
Published 2023-07-01Subjects: Get full text
Article -
13
TrkB agonistic antibodies superior to BDNF: Utility in treating motoneuron degeneration
Published 2019-12-01Subjects: Get full text
Article -
14
The Modulation of Fibrosis in Vocal Fold Repair: A Study on c-Met Agonistic Antibodies and Hepatocyte Growth in Animal Studies
Published 2024-12-01Subjects: Get full text
Article -
15
Development and characterization of a novel human CD137 agonistic antibody with anti‐tumor activity and a good safety profile in non‐human primates
Published 2022-12-01Subjects: Get full text
Article -
16
Cervical Cancer Cells Use the CD95 and IL-2 Pathways to Promote Their Proliferation and Survival
Published 2024-12-01Subjects: Get full text
Article -
17
Next Generation CD40 Agonistic Antibodies for Cancer Immunotherapy
Published 2022-07-01Subjects: Get full text
Article -
18
-
19
Erratum: Antibody-based soluble and membrane-bound TWEAK mimicking agonists with FcγR-independent activity
Published 2023-12-01Subjects: “…agonistic antibodies…”
Get full text
Article -
20
Antibody-based soluble and membrane-bound TWEAK mimicking agonists with FcγR-independent activity
Published 2023-07-01Subjects: “…agonistic antibodies…”
Get full text
Article